Lin Tai

2.6k citations

27 papers · 1.4k indexed · h-index 13

Impact in

Immunology top 10%
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
Molecular Biology top 10%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Ubiquitin and proteasome pathways

Papers in ⓘ

Oncology 15
- Cancer-related Molecular Pathways 7
- CAR-T cell therapy research 6
Pathology and Forensic Medicine 6
- Lymphoma Diagnosis and Treatment 3
- Cancer Mechanisms and Therapy 3

Co-authors: Andreas Strasser (21 shared papers)Marco J. Herold (17 shared papers)Gemma L. Kelly (7 shared papers)Margs S. Brennan (3 shared papers)Philippe Bouillet (4 shared papers)Andrew J. Kueh (7 shared papers)Brandon J. Aubrey (5 shared papers)Liz Milla (3 shared papers)
Journals: Cell Death and Differentiation (7 papers)Blood (3 papers)Cell (2 papers)EMBO Reports (2 papers)Progress in Natural Science Materials International (1 paper)
Partner nations: Australia United Kingdom China

In The Last Decade

Lin Tai

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by Lin Tai

Since Specialization

Citations

This map shows the geographic impact of Lin Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Tai more than expected).

Fields of papers citing papers by Lin Tai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Tai. The network helps show where Lin Tai may publish in the future.

Co-authors

The 25 scholars most cited alongside Lin Tai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lin Tai Line = papers co-authored together Lin Tai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Membrane-bound Fas ligand only is essential for Fas-induced apoptosis Nature ·Lorraine A. O’ Reilly, Lin Tai, Lily Lee, Elizabeth Kruse, Stephanie Grabow, W. Douglas Fairlie, Nicole M. Haynes, David M. Tarlinton, Jian‐Guo Zhang, Gabrielle T. Belz, Mark J. Smyth, Philippe Bouillet, Lorraine Robb, Andreas Strasser	2009	300
2	An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo Cell Reports ·Brandon J. Aubrey, Gemma L. Kelly, Andrew J. Kueh, Margs S. Brennan, Liam O’Connor, Liz Milla, Stephen Wilcox, Lin Tai, Andreas Strasser, Marco J. Herold	2015	272
3	The BH3-Only Protein Bid Is Dispensable for DNA Damage- and Replicative Stress-Induced Apoptosis or Cell-Cycle Arrest Cell ·Thomas Kaufmann, Lin Tai, Paul G. Ekert, David C.S. Huang, Fiona Norris, Ralph K. Lindemann, Ricky W. Johnstone, Vishva M. Dixit, Andreas Strasser	2007	159
4	Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53 Genes & Development ·Gemma L. Kelly, Stephanie Grabow, Stefan Glaser, Leah Fitzsimmons, Brandon J. Aubrey, Toru Okamoto, Liz J. Valente, Mikara Robati, Lin Tai, W. Douglas Fairlie, Erinna F. Lee, Mikael S. Lindström, Klas G. Wiman, David C.S. Huang, Philippe Bouillet, Martin Rowe, Alan B. Rickinson, Marco J. Herold, Andreas Strasser	2014	126
5	Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis Cell Death and Differentiation ·Ewa M. Michalak, Elisa S. Jansen, Lina Happo, Mark S. Cragg, Lin Tai, Gordon K. Smyth, Andreas Strasser, Jerry M. Adams, Clare L. Scott	2009	126
6	DNA repair processes are critical mediators of p53-dependent tumor suppression Nature Medicine ·Ana Janic, Liz J. Valente, Matthew J. Wakefield, Leon Di Stefano, Liz Milla, Stephen Wilcox, Haoyu Yang, Lin Tai, Cassandra J. Vandenberg, Andrew J. Kueh, Shinsuke Mizutani, Margs S. Brennan, Robyn L. Schenk, Lisa Lindqvist, Anthony T. Papenfuss, Liam O’Connor, Andreas Strasser, Marco J. Herold	2018	119
7	BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice Cell Death and Differentiation ·Francine Ke, Anne K. Voss, J. B. Kerr, Lorraine A. O’Reilly, Lin Tai, N Echeverry, Philippe Bouillet, Andreas Strasser, Thomas Kaufmann	2012	89
8	Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use Blood ·Margs S. Brennan, Catherine Chang, Lin Tai, Guillaume Lessène, Andreas Strasser, Grant Dewson, Gemma L. Kelly, Marco J. Herold	2018	66
9	Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment Cell Death and Differentiation ·Robyn L. Schenk, Selma Tuzlak, Emma M. Carrington, Yifan Zhan, Susanne Heinzel, Charis E. Teh, Daniel H.D. Gray, Lin Tai, Andrew M. Lew, Andreas Villunger, Andreas Strasser, Marco J. Herold	2017	51
10	Foxo‐mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3‐only protein EMBO Reports ·Marco J. Herold, Leona Rohrbeck, Mathias Jakob Lang, Raelene J. Grumont, Steve Gerondakis, Lin Tai, Philippe Bouillet, Thomas Kaufmann, Andreas Strasser	2013	26
11	The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival Leukemia ·Pasquale L. Fedele, Yang Liao, Jianan Gong, Yuan Yao, Mark F. van Delft, Michael Löw, Lin Tai, Marco J. Herold, Jacob T. Jackson, Charis E. Teh, Tania Tan, Lorraine A. O’Reilly, Julie Tellier, George Grigoriadis, David C.S. Huang, Wei Shi, Stephen L. Nutt, Simon N. Willis	2020	21
12	Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM Cell Death and Differentiation ·Leona Rohrbeck, Jianan Gong, Erinna F. Lee, Andrew J. Kueh, Andreas Behren, Lin Tai, Guillaume Lessène, David C.S. Huang, W. Douglas Fairlie, Andreas Strasser, Marco J. Herold	2016	21
13	BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines Blood Advances ·Sarah T. Diepstraten, Catherine Chang, Lin Tai, Jianan Gong, Ping Lan, Alexander C. Dowell, Graham S. Taylor, Andreas Strasser, Gemma L. Kelly	2020	16
14	Monoclonal antibodies to bovine a-crystallin Current Eye Research ·Robert C. Augusteyn, R Seifert, Lin Tai, Christopher H. Thompson	1985	11
15	Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types Genomics ·Yanjiao Zhu, Yichuan Zhao, Siyao Dong, Lu Liu, Lin Tai, Yan Xu	2019	10
16	RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice The Journal of Experimental Medicine ·Alex R. D. Delbridge, Swee Heng Milon Pang, Cassandra J. Vandenberg, Stephanie Grabow, Brandon J. Aubrey, Lin Tai, Marco J. Herold, Andreas Strasser	2016	10
17	Response: Does Bid Play a Role in the DNA Damage Response? Cell ·Thomas Kaufmann, Lin Tai, Paul G. Ekert, David C.S. Huang, Fiona Norris, Ralph K. Lindemann, Ricky W. Johnstone, Vishva M. Dixit, Damien Arnoult, Andreas Strasser	2007	7
18	Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses Cell Death and Differentiation ·John E. La Marca, Brandon J. Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew J. Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne K. Voss, Andreas Strasser, Sarah T. Diepstraten, Marco J. Herold, Gemma L. Kelly	2023	5
19	Removal of BFL-1 sensitises some melanoma cells to killing by BH3 mimetic drugs Cell Death and Disease ·Lahiru Gangoda, Robyn L. Schenk, Lin Tai, Pacman Szeto, Jen G. Cheung, Andreas Strasser, Guillaume Lessène, Mark Shackleton, Marco J. Herold	2022	3
20	Characterization of a novel human BFL-1-specific monoclonal antibody Cell Death and Differentiation ·Lahiru Gangoda, Charis E. Teh, Michael A. Dengler, Sarah A. Best, Clare E. Weeden, Lin Tai, Erinna F. Lee, W. Douglas Fairlie, (unknown), Leonard C. Harrison, Daniel H.D. Gray, Andreas Strasser, Marco J. Herold	2019	3

About Lin Tai

Lin Tai is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Immunology and Genetics, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (8 papers), Cancer-related Molecular Pathways (7 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), RNA modifications and cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Immunology (418 citations), Molecular Biology (1.1k citations), Oncology (428 citations), Cancer Research (174 citations) and Business and International Management (20 citations). Lin Tai has collaborated with scholars based in Australia, United Kingdom and China. Frequent co-authors include Andreas Strasser, Marco J. Herold, Gemma L. Kelly, Margs S. Brennan, Philippe Bouillet, Andrew J. Kueh, Brandon J. Aubrey, Liz Milla, Liam O’Connor and Stephen Wilcox. Their work appears in journals such as Cell Death and Differentiation, Blood, Cell, EMBO Reports and Progress in Natural Science Materials International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact